home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Combination Therapy Improves Rheumatoid Arthritis Symptoms

  April, 12 2006 9:23
your information resource in human molecular genetics
A rheumatologist proposes an improved treatment policy for people with early rheumatoid arthritis in the May 2006 issue Nature Clinical Practice Rheumatology. He recommends a combination drug therapy for early rheumatoid arthritis if symptoms can't be alleviated with the usual treatment, nonsteroidal anti-inflammatory drugs.

John Kirwan comments on the largest study to date to find improvement in the symptoms of early rheumatoid arthritis after 2 years of this combination therapy. Patients took a low-dose glucocorticoid, prednisolone, in combination with routine medications called DMARDs (disease-modifying antirheumatic drugs). Low-dose glucocorticoids are the only drugs that can stop the joint destruction caused by rheumatoid arthritis, whereas other treatments can only slow the damage.

Glucocorticoid drugs are often shunned because of side effects, like osteoporosis (fragile bones), in people who took high doses of these drugs in the past. Kirwan notes that a low dose of prednisolone does not appear to cause osteoporosis, at least during only 2 years of treatment.

Author Contact

John Kirwan (University of Bristol, UK)

Editor contact

Emma Campbell, (Editor, Nature Clinical Practice Rheumatology)
E-mail: e.campbell@nature.com

(C) Nature Clinical Practice Rheumatology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.